OCUNEXUS THERAPEUTICS
Ocunexus Therapeutics is a biopharmaceutical company that develops therapeutics for unmet clinical needs in ophthalmology. The company specializes in developing highly differentiated drug candidates based upon a novel mechanism of action called “Gap Junction Channel Modulation.” It has developed treatments for multiple front- and back-of-the-eye diseases and disorders that would potentially alter the standard of care. In addition, the company's technologies are expected to be transferable to other acute and chronic disease indications. Ocunexus is formerly known as CoDa Therapeutics, a pharmaceutical company focused on the development and commercialization of wound care therapeutics based on gap junction modulation. The company is based in San Diego, California.
OCUNEXUS THERAPEUTICS
Industry:
Biotechnology Health Care Medical Pharmaceutical Therapeutics
Founded:
2005-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.ocunexus.com
Total Employee:
1+
Status:
Closed
Contact:
(858) 677-0474
Email Addresses:
[email protected]
Total Funding:
78.59 M USD
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Current Advisors List
Current Employees Featured
Founder
Investors List
BioPacific Ventures
BioPacific Ventures investment in Series B - Ocunexus Therapeutics
RMI Partners
RMI Partners investment in Series B - Ocunexus Therapeutics
GBS Ventures
GBS Ventures investment in Series B - Ocunexus Therapeutics
Domain Associates
Domain Associates investment in Series B - Ocunexus Therapeutics
Square 1 Bank
Square 1 Bank investment in Debt Financing - Ocunexus Therapeutics
BioPacific Ventures
BioPacific Ventures investment in Series B - Ocunexus Therapeutics
GBS Ventures
GBS Ventures investment in Series B - Ocunexus Therapeutics
Domain Associates
Domain Associates investment in Series B - Ocunexus Therapeutics
Domain Associates
Domain Associates investment in Series A - Ocunexus Therapeutics
GBS Ventures
GBS Ventures investment in Series A - Ocunexus Therapeutics